TILs from neuroblastoma lesions expanded on average 15-fold during the pre-REP phase, and 200-fold during the second 2 wk of expansion with αCD3 and IL-2 (REP phase), resulting in a total expansion of ∼1,500-fold (Fig 2A). Here, IL2 is linked to neuroblastoma.